For: | Voutsadakis IA. Immune blockade inhibitors and the radiation abscopal effect in gastrointestinal cancers. World J Gastrointest Oncol 2018; 10(9): 221-227 [PMID: 30254717 DOI: 10.4251/wjgo.v10.i9.221] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v10/i9/221.htm |
Number | Citing Articles |
1 |
Puxiu Wang, Ping Chen, Weiting Yang, Wenhan Yang, Wenqi Liu, Song Yue, Qiuhua Luo. Prognostic and predictive factors in advanced upper gastrointestinal cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis of the current evidence. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12998-w
|
2 |
Yuta Kuhara, Motoki Ninomiya, Satoshi Hirahara, Hirofumi Doi, Shirakawa Kenji, Kazuhiro Toyota, Raita Yano, Hironori Kobayashi, Yasushi Hashimoto, Yujiro Yokoyama, Yoshihiro Sakashita, Katsunari Miyamoto. A long-term survival case of unresectable gastric cancer with multidisciplinary therapy including immunotherapy and abscopal effect. International Cancer Conference Journal 2020; 9(4): 193 doi: 10.1007/s13691-020-00433-3
|
3 |
Ioannis A. Voutsadakis. Clinical Implications of Chromosomal Instability (CIN) and Kinetochore Abnormalities in Breast Cancers. Molecular Diagnosis & Therapy 2019; 23(6): 707 doi: 10.1007/s40291-019-00420-2
|
4 |
Andreas Henriksen, Anne Dyhl-Polk, Inna Chen, Dorte Nielsen. Checkpoint inhibitors in pancreatic cancer. Cancer Treatment Reviews 2019; 78: 17 doi: 10.1016/j.ctrv.2019.06.005
|
5 |
Anne Dyhl-Polk, Marta Kramer Mikkelsen, Morten Ladekarl, Dorte Lisbet Nielsen. Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma. Journal of Clinical Medicine 2021; 10(12): 2662 doi: 10.3390/jcm10122662
|